FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1541-1542 May 21, 1998 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Redelmeier, D. A. PubMed Citation

How many medications are optimal for a patient with multiple medical problems? Prescribing too many increases the likelihood of side effects, drug interactions, and poor compliance. Prescribing too few may leave important conditions or symptoms untreated. Of course, there is no correct answer to such a simplistic question. However, in a provocative article in this issue of the Journal, Redelmeier and colleagues argue that physicians frequently undertreat patients with multiple chronic medical conditions.¹

Redelmeier et al. conducted a clever study of all residents of Ontario, Canada, who were eligible to receive prescription medications free of charge as part of the . . . [Full Text of this Article]

References

Related Letters:

Treating Unrelated Disorders in Patients with Chronic Disease
Kent D. M., Hayward R., Rubins H. B., Friedman E. A., Poses R. M., Redelmeier D. A., Tan S. H., Booth G. L.
Extract | Full Text  
N Engl J Med 1998; 339:926-928, Sep 24, 1998. Correspondence

This article has been cited by other articles:

• Huang, E. S., Brown, S. E.S., Thakur, N., Carlisle, L., Foley, E., Ewigman, B., Meltzer, D. O. (2009). Racial/Ethnic Differences in Concerns About Current and Future Medications Among Patients With Type 2 Diabetes. Diabetes Care 32: 311-316 [Abstract] [Full Text]  
• Austin, R. P. (2006). Polypharmacy as a Risk Factor in the Treatment of Type 2 Diabetes. Diabetes Spectr. 19: 13-16 [Full Text]  
• Wang, P. S., Avorn, J., Brookhart, M. A., Mogun, H., Schneeweiss, S., Fischer, M. A., Glynn, R. J. (2005). Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly Hypertensives. Hypertension 46: 273-279 [Abstract] [Full Text]  
• McAlister, F. A., Stewart, S., Ferrua, S., McMurray, J. J.J.V. (2004). Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol 44: 810-819 [Abstract] [Full Text]  
• Hilliard, A. A., Weinberger, S. E., Tierney, L. M. Jr., Midthun, D. E., Saint, S. (2004). Occam's Razor versus Saint's Triad. NEJM 350: 599-603 [Full Text]  
• Rochon, P. A., Gurwitz, J. H. (1999). Prescribing for Seniors: Neither Too Much nor Too Little. JAMA 282: 113-115 [Full Text]  
• Fisher, E. S., Welch, H. G. (1999). Avoiding the Unintended Consequences of Growth in Medical Care: How Might More Be Worse?. JAMA 281: 446-453 [Abstract] [Full Text]  
• Kent, D. M., Hayward, R., Rubins, H. B., Friedman, E. A., Poses, R. M., Redelmeier, D. A., Tan, S. H., Booth, G. L. (1998). Treating Unrelated Disorders in Patients with Chronic Disease. NEJM 339: 926-928 [Full Text]  
• Richards, T. (1998). Disease management in Europe. BMJ 317: 426-427 [Full Text]